About Vania Nose, MD, PhD

Dr. Nose is a surgical pathologist with subspecialty expertise in endocrine pathology. She has served as a consultant for difficult endocrine pathology cases locally, regionally, and internationally. Dr. Nose has published extensively on endocrine pathology, tumor pathology, and also in molecular aspects of neoplasia with over 150 peer-reviewed articles. Dr. Nose has described the pathological classification of familial thyroid tumors, inherited tumor syndromes, as well as the pituitary pathology synoptic reporting. She is the author of the CAP endocrine pathology competencies. She had served on the editorial boards of numerous pathology journals and is a past President of the Endocrine Pathology Society. Dr. Nose authored a comprehensive textbook in endocrine pathology titled "Diagnostic Pathology: Endocrine."

Departments, Centers, & Programs:

Clinical Interests:




Mass General Pathology
55 Fruit St.
Boston, MA 02114
Phone: 617-643-0800

Medical Education

  • MD, State University of Campinas School of Medical Sciences
  • Residency, Boston Children's Hospital
  • Residency, Boston Medical Center
  • Residency, Mallory Institute, Boston City Hospital
  • Residency, New England Deaconess Hospital
  • Residency, New England Deaconess Hospital
  • Residency, Rhode Island Hospital/Lifespan

American Board Certifications

  • Anatomic Pathology, American Board of Pathology
  • Clinical Pathology, American Board of Pathology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


  • Son E, Nose V. Familial follicular cell-derived thyroid carcinoma.Front Endocrinol (Lausanne). 2012;3:61

    Nose V, et al. Protocol for the examination of specimens from patients with primary pituitary tumors. Arch Pathol Lab Med.2011;135(5):640-6

    Nose V. Familial thyroid cancer: a review. Mod Pathol.2011;24 S2:S19-33

    Chen J, Faquin W, Lloyd R, Nose V. Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma.Mod Pathol.2011;24(5):739-49

    Laury A, et al, Nose V. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity. Thyroid. 2011;21(2):135-44

    Nose V. Thyroid cancer of follicular cell origin in inherited tumor syndromes. Adv Anat Pathol. 2010;17(6):428-36

    Sadow P,et al, Nose V. Absence of BRAF,NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas. EndocrPathol.2010;21(2):73-9

    Nose V. Familial follicular cell tumors:classification and morphological characteristics. EndocrPathol.2010;21(4):219-26

    Schmidt J, et al, Nose V. BRAF in papillary thyroid carcinoma of ovary (struma ovarii). Am J Surg Pathol. 2007;31(9):1337-43

    Reimann J, Dorfman D, Nose V.  Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): a comparative study: evidence of thymic differentiation  and solid cell nest origin. Am J Surg Pathol. 2006;30(8):994-1001

Reviews: Comments and Ratings